くすりの有害事象と薬剤疫学
CzeekV実践活用と最先端技術情報をシェアします
このサイトについて
CzeekVとは
CzeekV実践
論文・技術情報
薬剤疫学・DB研究
CzeekV ログデータグラフ
CzeekV アナリティクス
お問合わせ
検索結果
P-Glycoprotein Mediated Interaction is A Risk Factor For Qt Prolongation in Concomitant Use of Antipsychotics and Ssris As P-Glycoprotein Mediated Inhibitors: Analysis of The Japanese Adverse Drug Event Report Database.
タグ:
JADER
2023/9/2
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan.
タグ:
JADER
2023/9/15
Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature.
タグ:
JADER
2023/8/9
Profiles and Outcomes of Skin Injuries Caused by Injectable Drug Extravasation: An Analysis of the Japanese Adverse Drug Event Report Database.
タグ:
JADER
2023/8/23
Evaluation of time to onset and outcome of cardiac adverse events associated with nilotinib using post-marketing surveillance.
タグ:
JADER
2023/8/21
Evaluation of time to onset and outcome of lung adverse events related to pembrolizumab using marketing surveillance.
タグ:
JADER
2023/8/18
Disproportionality Analysis on Hypothyroidism With Roxadustat Using the Japanese Adverse Drug Event Database.
タグ:
JADER
2023/7/6
Analysis of Corticosteroid-Induced Glaucoma Using the Japanese Adverse Drug Event Reporting Database.
タグ:
JADER
2023/7/29
Structural characterization of the optical isomers esomeprazole and omeprazole using the JADER and FAERS databases.
タグ:
FAERS
JADER
2023/7/24
COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database.
タグ:
JADER
2023/7/17
1
2
...
30
>
検索
サイト内検索・論文検索
検索
サイト内
論文
キーワード
PubmedID
Abstract
Title
Journal
Date(投稿日)
~
Author
タクソノミー検索
タクソノミー検索
CAERS
CARD
CPRD
CVAR
CVARD
DeSC
DPC
EHR
ESP-VAERS
EudraVigilance
FAERS
Fibroblasts
FPVD
GPRD
Ionizing
JADER
JMDC
KAERS
KIDS-KAERS
KIDS-KD
MDV
NDB
Nickel
Pharmacoepidemiology
Radiation
RWE
THIN
Unknown
VAERS
VigiBase
インフォメーション
スコア値
スコア指標
総合ランキング
閾値
メルマガ登録
購読申し込み
お問合わせ
お問合わせ